Type I autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 7, 2006, Pages 1051-1057

  Floreani, A ^a   Niro, G ^b   Rosa Rizzotto, E ^a   Antoniazzi, S ^a   Ferrara, F ^a   Carderi, I ^a   Baldo, V ^a   Premoli, A ^c   Olivero, F ^c   Morello, E ^c   Durazzo, M ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; NIMESULIDE; PREDNISOLONE; PREDNISONE; THORVASTATIN; TRAZODONE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG HYPERSENSITIVITY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTHROMBIN TIME; REMISSION; SURVIVAL RATE;

ADULT; BIOLOGICAL MARKERS; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; ITALY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33748653157     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03104.x     Document Type: Article

References (22)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
2. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99-103.
3. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
4. Czaja AJ. Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 1999; 57: 49-68.
5. Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 357: 7-13.
6. Czaja AJ, Bianchi FB, Carpenter HA, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005; 41: 207-15.
7. Johnson P, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-63.
8. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006; 43: 532-8.
9. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005; 42: 53-62.
10. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
11. Newton JL, Burt AD, Park JB, Matthew J, Bassendine MF, James OFW. Autoimmune hepatitis in older patients. Age Ageing 1997; 26: 441-4.
12. Parker DR, Kingham JGC. Type I autoimmune hepatitis is primarily a disease of later life. Q J Med 1997; 90: 289-96.
13. Schramm C, Kanzler S, zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001; 96: 1587-91.
14. Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002; 25: 633-48.
15. Conforti A, Leone R, Ghiotto E, et al. Spontaneous reporting of drug-related hepatic reactions from two Italian regions (Lombardy and Veneto). Dig Liver Dis 2000; 32: 16-23.
16. Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001; 48: 97-102.
17. Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101: 556-60.
18. Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002; 97: 3160-5.
19. Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in early post partum period. Clin Gastroenterol Hepatol 2004; 2: 622-4.
20. Omagari K, Kinoshita H, Kato Y, et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 1999; 34: 221-6.
21. Kanzler S, Lohr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001; 39: 339-41.
22. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type I autoimmune hepatitis. Gastroenterology 1996; 110: 848-57.